SEMA3E and asthma: Although the impact of Sema3E has been investigated in the acute and chronic HDM models of asthma [14–16,19,20,22,23,25], which represent type-2 high asthma in humans, its role in type-2 low or neutrophilic asthma using cyclic-di-GMP remains unexplored.